• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC PUERTO RICO OPERATIONS CO. SYNCHROMED II; PUMP, INFUSION, IMPLANTED, PROGRAMMABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC PUERTO RICO OPERATIONS CO. SYNCHROMED II; PUMP, INFUSION, IMPLANTED, PROGRAMMABLE Back to Search Results
Model Number 8637-40
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hemorrhage/Bleeding (1888); Muscle Spasm(s) (1966); Overdose (1988); Complaint, Ill-Defined (2331); Sedation (2368); Weight Changes (2607)
Event Date 02/23/2018
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Information was received from a consumer regarding a patient receiving baclofen ("does" and concentration not reported) via an implantable pump.The indications for use were intractable spasticity and cerebral palsy.The patient¿s medical history included a cervical issue due to a car accident and cervical surgery.On 15-jan-2019 it was reported that the patient was in the hospital in (b)(6) 2018 because they thought the medication was too high of dose and sedating the patient.The patient was in the icu (intensive care unit) and they ¿adjusted the pump¿ from ¿1100 to something¿.Additional information was received on 17-jan-2019 from the healthcare provider who reported that the patient was not in the icu (intensive care unit) there and had no additional information on where they would have been in the icu.The healthcare provider further reported that the patient was seen on (b)(6) 2018 for blood, reported by the patient as "bleeding to death," coming from the incision site from the replacement surgery on (b)(6) 2018.The healthcare provider indicated that there was minimal blood at the incision site and no wound dehiscence.A follow-up by a nurse practitioner on (b)(6) 2018 indicated no bleeding at the incision site.A follow-up by a nurse practitioner on (b)(6) 2018 indicated the wound had not dehisced, that the wound looked good, and that they were cleared to undergo a cervical surgery that was stated unrelated to the patient¿s infusion system.The healthcare provider indicated that they had no additional information to report.Additional information was received from the patient¿s mother who reported that the patient was not in the icu (intensive care unit) in (b)(6) 2018 as initially reported but in (b)(6) 2018.Per the patient¿s mother, the patient was in the icu because of the sedation the drug was causing.No other interventions were performed, and the patient recovered.The patient then began having spasms about 30 days after the pump was turned down in (b)(6) 2018, since they had not turned it back up.The reporter stated that they were not sure if there was something wrong with the pump, but they may be getting a dye study.No further complications were reported or anticipated.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional information was received from a consumer indicated the patient was having some issues and going back and forth.It was reported the patient has had spasms and the spasms were getting worse.The patient had lost weight as a result since implant in (b)(6) 2018.It was further reported the pump was turned up so high" a company representative (rep) came and adjusted his pump when the patient was in the icu and they said the pump may have been giving too much drug, so the rep came to turn pump down in (b)(6) 2019.The patient was asking about dosing of drug over a period of time.The caller was to follow-up with the healthcare provider (hcp).It was noted the change in therapy/symptoms was gradual.The event date was (b)(6) 2018.No further complications were reported or anticipated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNCHROMED II
Type of Device
PUMP, INFUSION, IMPLANTED, PROGRAMMABLE
Manufacturer (Section D)
MEDTRONIC PUERTO RICO OPERATIONS CO.
road 31, km. 24, hm 4
ceiba norte industrial park
juncos PR 00777
Manufacturer (Section G)
MEDTRONIC PUERTO RICO OPERATIONS CO.
road 31, km. 24, hm 4
ceiba norte industrial park
juncos PR 00777
Manufacturer Contact
lisa woodward clark
7000 central avenue ne rcw215
minneapolis, MN 55432
7635263920
MDR Report Key8261630
MDR Text Key133560814
Report Number3004209178-2019-01331
Device Sequence Number1
Product Code LKK
UDI-Device Identifier00643169530126
UDI-Public00643169530126
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P860004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,health professional
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 09/17/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/18/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date07/14/2019
Device Model Number8637-40
Device Catalogue Number8637-40
Was Device Available for Evaluation? No
Date Manufacturer Received09/12/2019
Date Device Manufactured01/20/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening;
Patient Age28 YR
-
-